Loading...
Maintained Complete Response and Long-Term Survival in Epidermal Growth Factor Receptor Mutated Metastatic Non-Small Cell Lung Cancer with Erlotinib
The prognosis of advanced non-small cell lung cancer (NSCLC) has significantly improved for certain patients with the development of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). However, metastatic NSCLC patients with long-term survival are still rare. Our 66-year-old mal...
Na minha lista:
| Udgivet i: | Cureus |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Cureus
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7853695/ https://ncbi.nlm.nih.gov/pubmed/33552769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.12451 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|